Summer Sale
50% off Premium Yearly
Opinions Jim Cramer - Mad Money
Piper Sandler CompaniesPIPRBUYApr 08, 2024
Jim Cramer - Mad MoneyStock price when the opinion was issued
As of Jun 15, 2026. Market Open.
You might be interested:
The recovery in M&A in smaller companies has been delayed due to geopolitical noise, and there's been repricing in software down which discourages software deals, but this will change. Still likes PIPR.
Julien Nono-WomdimIt is in technology and health care where IPO's have been in a drought. However we are entering a new revived IPO market which need a stable environment for them to do well. IPO's in 2017/2018 had only top line growth but adjustments have happened and that has changed. We should see operating leverage and margin expansion. The Geo-political backdrop has normalized after a flight away from the space.
Buy 1 Hold 3 Sell 0
Julien Nono-WomdimA mid-cap bank with a strong presence in health care and government. They've bought companies in these sectors. They are part of the next wave in financials. There's pent-up demand to do capital markets business, given the Biden restrictions.
(Analysts’ price target is $355.50)
Gordon ReidGordon Reid(A Top Pick Jun 17/20, Up 113%) See comments on JPMorgan about capital markets business, which has been sizzling. Lots of synergies from the January 2020 merger. There's tons of liquidity in the market which continues to fuel PIPR. It's unrealistic for this stock to double again, but this will do well.
Gordon ReidGordon ReidGordon Reid
Slumped in 2022-3 along with capital markets, but has rebounded strongly since late last year with 49% revenue growth in Q4 and 129% earnings growth. Has rallied hard since late-October. Trades at only 17x PE. Will do well with more IPOs to come.